Dopamine Uptake InhibitorsBenztropineDopamineNomifensineCocaineReceptors, Dopamine D2Dopamine Plasma Membrane Transport ProteinsCorpus StriatumDopamine AntagonistsNeurotransmitter Uptake InhibitorsPiperazinesReceptors, Dopamine D1Receptors, DopamineDopamine AgonistsReceptors, Dopamine D3NeostriatumMazindolTropanesRacloprideDopamine AgentsSynaptosomes3,4-Dihydroxyphenylacetic AcidMethamphetamineMicrodialysisRats, Sprague-DawleyNucleus AccumbensHomovanillic AcidAmphetamineSubstantia NigraAdrenergic Uptake InhibitorsCaudate NucleusReceptors, Dopamine D5Membrane Transport ProteinsSalicylamidesSerotoninMotor ActivityOxidopamineTyrosine 3-MonooxygenaseGABA Uptake InhibitorsBehavior, AnimalDose-Response Relationship, DrugNerve Tissue ProteinsLevodopaVesicular Monoamine Transport ProteinsDopamine beta-HydroxylaseNorepinephrine Plasma Membrane Transport ProteinsQuinpiroleBenzazepinesDopaminergic NeuronsNeuronsBiogenic MonoaminesMesencephalonMethylphenidate1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineHaloperidolMPTP PoisoningBrainBasal GangliaDopamine and cAMP-Regulated Phosphoprotein 32NorepinephrineApomorphineParkinsonian DisordersDihydroxyphenylalanineStereotyped BehaviorPutamenDesipramineNipecotic AcidsZimeldineCentral Nervous System StimulantsSerotonin Uptake InhibitorsTetrabenazineMembrane GlycoproteinsParkinson Disease, SecondaryFluoxetineMedial Forebrain BundleCocaine-Related DisordersPositron-Emission TomographyDrug Interactionsalpha-MethyltyrosineBrain ChemistryPyrrolidinesSpiperoneDextroamphetamineLobelineSelf AdministrationSulpirideBiological TransportRewardDyskinesia, Drug-InducedCarbidopaTime FactorsSerotonin AntagonistsMembrane Transport ModulatorsReserpineCarrier ProteinsParkinson DiseasePargylineClomipramineAntiparkinson AgentsTritium